Trending
October 1, 2024 Luxa Biotechnology Appoints Keith E. Dionne, Ph.D., as Chief Executive OfficerOctober 1, 2024 T. Rowe Price Funds Join $175M Series B for Aktis OncologySeptember 23, 2024 Maternal Health Startup Canopie Raises $3.7 MillionSeptember 20, 2024 Traws Pharma Appoints Luba Greenwood to Board of DirectorsSeptember 18, 2024 Main Line Health CEO Jack Lynch to Retire
Featured
October 1, 2024
Luxa Biotechnology Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer
FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC, a clinical -stage biotechnology company developing a novel... Read more »
October 1, 2024
T. Rowe Price Funds Join $175M Series B for Aktis Oncology
Boston-headquartered Aktis Oncology, a clinical-stage biotechnology company developing alpha radiopharmaceuticals to... Read more »
September 23, 2024
Maternal Health Startup Canopie Raises $3.7 Million
Virginia Venture Partners-backed Canopie, a maternal health startup, has raised $3.7 million in a seed round co-led by... Read more »
October 1, 2024
Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical
September 30, 2024
NRx Pharmaceuticals Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine)
